Prof Josep Tabernero, Vall d'Hebron Institute of Oncology, Barcelona, Spain, talks to ecancer Managing Editor Prof Gordon McVie about research he presented at the 2011 European Multidisciplinary Cancer Conference, Stockholm. Results From VELOUR, a Phase III Study of Aflibercept (A) Versus Placebo (pbo) in Combination with FOLFIRI for the Treatment of Patients with Previously Treated Metastatic Colorectal Cancer (MCRC). FOL – folinic acid (leucovorin), F – fluorouracil (5-FU) and IRI – irinotecan.